151 related articles for article (PubMed ID: 2837467)
1. Properties of a human insulin receptor with a COOH-terminal truncation. I. Insulin binding, autophosphorylation, and endocytosis.
McClain DA; Maegawa H; Levy J; Huecksteadt T; Dull TJ; Lee J; Ullrich A; Olefsky JM
J Biol Chem; 1988 Jun; 263(18):8904-11. PubMed ID: 2837467
[TBL] [Abstract][Full Text] [Related]
2. Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects.
Maegawa H; McClain DA; Freidenberg G; Olefsky JM; Napier M; Lipari T; Dull TJ; Lee J; Ullrich A
J Biol Chem; 1988 Jun; 263(18):8912-7. PubMed ID: 2837468
[TBL] [Abstract][Full Text] [Related]
3. A domain of the insulin receptor required for endocytosis in rat fibroblasts.
Thies RS; Webster NJ; McClain DA
J Biol Chem; 1990 Jun; 265(17):10132-7. PubMed ID: 2161833
[TBL] [Abstract][Full Text] [Related]
4. Phorbol ester-mediated protein kinase C interaction with wild-type and COOH-terminal truncated insulin receptors.
Anderson CM; Olefsky JM
J Biol Chem; 1991 Nov; 266(32):21760-4. PubMed ID: 1657981
[TBL] [Abstract][Full Text] [Related]
5. Augmented mitogenesis and impaired metabolic signaling mediated by a truncated insulin receptor.
Thies RS; Ullrich A; McClain DA
J Biol Chem; 1989 Aug; 264(22):12820-5. PubMed ID: 2753889
[TBL] [Abstract][Full Text] [Related]
6. A truncated human insulin receptor missing the COOH-terminal 365 amino acid residues does not undergo insulin-mediated receptor migration or aggregation.
Smith RM; Sasaoka T; Shah N; Takata Y; Kusari J; Olefsky JM; Jarett L
Endocrinology; 1993 Apr; 132(4):1453-62. PubMed ID: 8462446
[TBL] [Abstract][Full Text] [Related]
7. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine.
Ando A; Momomura K; Tobe K; Yamamoto-Honda R; Sakura H; Tamori Y; Kaburagi Y; Koshio O; Akanuma Y; Yazaki Y
J Biol Chem; 1992 Jun; 267(18):12788-96. PubMed ID: 1618780
[TBL] [Abstract][Full Text] [Related]
8. Insulin internalization in the absence of the insulin receptor tyrosine kinase domain is insufficient for mediating intracellular biological effects.
Schranz DB; Rohilla AM; Anderson C; Wood WM; Berhanu P
Biochem Biophys Res Commun; 1996 Oct; 227(2):600-7. PubMed ID: 8878559
[TBL] [Abstract][Full Text] [Related]
9. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.
McClain DA; Maegawa H; Lee J; Dull TJ; Ulrich A; Olefsky JM
J Biol Chem; 1987 Oct; 262(30):14663-71. PubMed ID: 3312193
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine kinase-defective insulin receptors undergo decreased endocytosis but do not affect internalization of normal endogenous insulin receptors.
Grako KA; Olefsky JM; McClain DA
Endocrinology; 1992 Jun; 130(6):3441-52. PubMed ID: 1317784
[TBL] [Abstract][Full Text] [Related]
11. Amino acid sequences Gly-Pro-Leu-Tyr and Asn-Pro-Glu-Tyr in the submembranous domain of the insulin receptor are required for normal endocytosis.
Rajagopalan M; Neidigh JL; McClain DA
J Biol Chem; 1991 Dec; 266(34):23068-73. PubMed ID: 1744103
[TBL] [Abstract][Full Text] [Related]
12. Endocytosis of insulin receptors is not required for activation or deactivation of the hormone response.
McClain DA
J Biol Chem; 1990 Dec; 265(34):21363-7. PubMed ID: 2174444
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild type insulin-like growth factor 1 or insulin receptors.
Langlois WJ; Sasaoka T; Yip CC; Olefsky JM
Endocrinology; 1995 May; 136(5):1978-86. PubMed ID: 7720646
[TBL] [Abstract][Full Text] [Related]
14. C-terminus or juxtamembrane deletions in the insulin receptor do not affect the glucose-dependent inhibition of the tyrosine kinase activity.
Mosthaf L; Berti L; Kellerer M; Mushack J; Seffer E; Bossenmaier B; Coghlan M; Siddle K; Ullrich A; Häring HU
Eur J Biochem; 1995 Feb; 227(3):787-91. PubMed ID: 7867639
[TBL] [Abstract][Full Text] [Related]
15. Normal insulin receptor substrate-1 phosphorylation in autophosphorylation-defective truncated insulin receptor. Evidence that phosphorylation of substrates might be sufficient for certain biological effects evoked by insulin.
Yamamoto-Honda R; Kadowaki T; Momomura K; Tobe K; Tamori Y; Shibasaki Y; Mori Y; Kaburagi Y; Koshio O; Akanuma Y
J Biol Chem; 1993 Aug; 268(22):16859-65. PubMed ID: 8344965
[TBL] [Abstract][Full Text] [Related]
16. Transmembrane signaling by an insulin receptor lacking a cytoplasmic beta-subunit domain.
Sasaoka T; Takata Y; Kusari J; Anderson CM; Langlois WJ; Olefsky JM
Proc Natl Acad Sci U S A; 1993 May; 90(10):4379-83. PubMed ID: 8506276
[TBL] [Abstract][Full Text] [Related]
17. Deletion of exon 21 of the insulin receptor eliminates tyrosine kinase activity but preserves mitogenic signaling.
Rolband GC; Williams JF; Webster NJ; Hsu D; Olefsky JM
Biochemistry; 1993 Dec; 32(49):13545-50. PubMed ID: 8257690
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of impaired metabolic signaling by a truncated human insulin receptor. Decreased activation of protein phosphatase 1 by insulin.
Begum N; Olefsky JM; Draznin B
J Biol Chem; 1993 Apr; 268(11):7917-22. PubMed ID: 8385127
[TBL] [Abstract][Full Text] [Related]
19. The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics.
Vogt B; Carrascosa JM; Ermel B; Ullrich A; Häring HU
Biochem Biophys Res Commun; 1991 Jun; 177(3):1013-8. PubMed ID: 1647764
[TBL] [Abstract][Full Text] [Related]
20. Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action.
McClain DA
Mol Endocrinol; 1991 May; 5(5):734-9. PubMed ID: 2072930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
